HbA1c News and Research

RSS

Whole grains, legumes and vegetables stand out in a major review of diabetes diets

Healthy plant-based diets rich in whole grains, legumes, fruits, vegetables, nuts, and seeds are associated with better glycemic control and a lower risk of type 2 diabetes. The review finds that food quality and processing matter more than simply avoiding animal foods, while unhealthy plant-based patterns and higher red and processed meat intake are associated with greater metabolic risk.

18 Aug 2026

Why keto appears to lower blood pressure for some people but not others

A narrative review finds that ketogenic diets may modestly lower blood pressure through weight loss, reduced visceral fat, improved insulin sensitivity, fluid and electrolyte shifts, and anti-inflammatory effects. However, effects vary across studies, long-term cardiovascular evidence remains limited, and diet quality, hydration, electrolyte balance, and medication monitoring are important.

17 Aug 2026

Researchers tracked biological aging for decades and found a striking pattern in women

Accelerated biological age in midlife was associated with higher risks of cardiovascular disease and death in both men and women over nearly three decades of follow-up. Women with accelerated biological age also showed a higher risk of dementia, although adding biological age to standard risk factors provided only minimal additional predictive value.

12 Aug 2026

Study links better midlife vascular health to nearly 13 more dementia-free years

A long-term study of 12,409 adults found that a greater burden of diabetes, hypertension, and current smoking in midlife was associated with substantially fewer years lived free of dementia. Adults with none of these risk factors had about 30.1 dementia-free years from age 55, compared with 17.5 years among those with all three, a difference of nearly 13 years.

10 Aug 2026

Why pulses could play a bigger role in healthy and sustainable diets

A narrative review finds that pulses may support gut and metabolic health through their fiber, protein, phytochemicals, and interactions with the gut microbiota, while offering a lower environmental footprint than many animal protein sources. Human evidence is strongest for selected cardiometabolic outcomes, while many microbiome and fermentation-related benefits remain supported mainly by animal and laboratory studies.

9 Aug 2026

Continuous glucose monitors show no proven benefits for healthy people

Continuous glucose monitors are becoming increasingly popular, including among people without diabetes.

4 Aug 2026

Study links lower vitamin D to mood and cognitive health in adults over 85 with diabetes

Researchers studying 188 adults aged 85 years or older with type 2 diabetes found the lowest serum 25(OH)D concentrations among those with both depressive symptoms and mild cognitive impairment. Lower levels remained associated with having both conditions after adjustment for selected factors, but the cross-sectional study cannot establish causation or a benefit from supplementation.

3 Aug 2026

Siemens Healthineers launches an industry-leading menu for core lab capillary testing on Atellica analyzers with claims for 24 assays

Siemens Healthineers announced today that it has launched capillary testing on the Atellica CH, IM, and CI Analyzers after receiving CE-mark for 24 capillary blood testing claims, an advancement for capillary testing that offers clinical labs greater confidence in test results and higher throughput.

From Siemens Healthineers 24 Jul 2026

Early electroacupuncture intervention protects pancreatic function in prediabetes

Prediabetes refers to a metabolic state in which blood glucose is higher than normal but has not yet reached the diagnostic threshold for diabetes. It may involve impaired fasting glucose, impaired glucose tolerance, or elevated glycated hemoglobin A1c (HbA1c), and is closely associated with progressive β-cell dysfunction.

21 Jul 2026

Medically tailored grocery deliveries improve blood sugar control among diabetes patients

A study from researchers at top US health insurance and medical services provider Kaiser Permanente, the Food is Medicine Institute at the Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy at Tufts University and The George Institute for Global Health found medically tailored grocery deliveries improved blood sugar control among adults living with type 2 diabetes who have public health insurance, when compared with usual care.

21 Jul 2026

Study tests chronotype’s liver link and finds no significant association

Researchers found no significant association between chronotype and FibroScan-derived liver fat or stiffness in 119 medication-naïve adults with overweight or obesity. The exploratory findings cannot exclude smaller effects, particularly for fibrosis, and require confirmation in larger longitudinal studies.

21 Jul 2026

Semaglutide vs. liraglutide: Head-to-head study reveals a diabetes risk difference

Researchers compared semaglutide with liraglutide in 57,456 insured adults without recorded diabetes or cardiovascular disease who initiated formulations indicated for chronic weight management. Semaglutide users had a lower risk of incident diabetes, particularly beyond six months of follow-up, but limited cardiovascular events prevented a precise comparison of cardiovascular risk.

20 Jul 2026

Diet helps people lose weight regardless of genetic obesity risk

A study reveals dietary coaching aids weight loss equally in individuals with high and low genetic obesity risk, challenging genetic determinism in weight loss.

17 Jul 2026

Evening chronotype links later eating with higher body fat

Research shows evening chronotypes in women consume more energy later, leading to higher body fat and metabolic issues, highlighting chrono-nutrition's role.

16 Jul 2026

GLP-1 receptor activation linked to lower depression and bipolar disorder odds

Genetic analyses linked BMI-related GLP-1 receptor activation to better mental well-being and lower odds of major depressive disorder and bipolar disorder. The findings do not prove that GLP-1 receptor agonist drugs treat psychiatric conditions, and randomized clinical trials are still needed.

15 Jul 2026

Semaglutide outperforms other GLP-1 drugs for weight loss in psychiatric populations

A network meta-analysis of nine randomized controlled trials found that once-weekly semaglutide showed the largest estimated weight-loss effect among GLP-1 receptor agonists tested in adults with mental illness and obesity or related metabolic risk. The authors cautioned that the findings remain preliminary because the evidence base was small, heterogeneous, and largely indirect.

9 Jul 2026

Yogurt, prebiotics, and probiotics link to lower colorectal cancer odds in U.S. adults

A national NHANES analysis of 9,405 U.S. adults aged 50 and older found that any yogurt, prebiotic, or probiotic consumption was associated with about 50% lower odds of self-reported colorectal cancer. Because the study was cross-sectional, it cannot prove causation but supports further research into microbiota-targeted dietary strategies.

8 Jul 2026

Trial supports glargine use in resource-limited Type 1 diabetes care

A trial led by University of Pittsburgh researchers and published today in The Lancet Diabetes & Endocrinology adds nuance to the question of whether older human insulins are as effective as insulin analogues in low-resource settings.

6 Jul 2026

Study links semaglutide and tirzepatide to fewer anxiety and depression diagnoses in obesity care

A US electronic health record study found that adults with obesity who started semaglutide or tirzepatide had lower recorded hazards of anxiety and depression than matched patients using naltrexone-bupropion. However, among adults without type 2 diabetes, tirzepatide was linked to higher recorded hazards of anxiety and insomnia than semaglutide, underscoring the need for cautious monitoring.

1 Jul 2026

Analysis shows artificial sweeteners may harm adult metabolism function

Since the first introduction of saccharin, an array of artificial and other non-nutritive (i.e., low-calorie or calorie-free) sweeteners have become ubiquitous in the US food supply.

30 Jun 2026

HbA1c News and Research

Whole grains, legumes and vegetables stand out in a major review of diabetes diets

Why keto appears to lower blood pressure for some people but not others

Researchers tracked biological aging for decades and found a striking pattern in women

Study links better midlife vascular health to nearly 13 more dementia-free years

Why pulses could play a bigger role in healthy and sustainable diets

Continuous glucose monitors show no proven benefits for healthy people

Study links lower vitamin D to mood and cognitive health in adults over 85 with diabetes

Siemens Healthineers launches an industry-leading menu for core lab capillary testing on Atellica analyzers with claims for 24 assays

Early electroacupuncture intervention protects pancreatic function in prediabetes

Medically tailored grocery deliveries improve blood sugar control among diabetes patients

Study tests chronotype’s liver link and finds no significant association

Semaglutide vs. liraglutide: Head-to-head study reveals a diabetes risk difference

Diet helps people lose weight regardless of genetic obesity risk

Evening chronotype links later eating with higher body fat

GLP-1 receptor activation linked to lower depression and bipolar disorder odds

Semaglutide outperforms other GLP-1 drugs for weight loss in psychiatric populations

Yogurt, prebiotics, and probiotics link to lower colorectal cancer odds in U.S. adults

Trial supports glargine use in resource-limited Type 1 diabetes care

Study links semaglutide and tirzepatide to fewer anxiety and depression diagnoses in obesity care

Analysis shows artificial sweeteners may harm adult metabolism function

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News